Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01110850 · ClinicalTrials.gov registry record
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 24
- Enrollment target
NCT01110850 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 24 participants.
The verdict
NCT01110850 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Chronic lymphocytic leukemia. B-cell chronic lymphocytic leukemia (B-CLL) is the most prevalent leukemia in the Western Hemisphere, accounting for \~25% of all leukemia's. It represents a monoclonal expansion of small, long-lived, apparently slowly dividing CD5+ B cells. Because of the low proliferative index and a presumed uniform proliferative rate of B-CLL cells in vivo (a fact not yet tested or documented), B-CLL appears to be primarily a disease of accumulation rather than proliferation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-06 |
| Est. Completion | 2018-05-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01110850
The ClinicalTrials.gov registry entry for NCT01110850 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01110850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01110850 about?
NCT01110850 is a clinical study titled "Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water". Chronic lymphocytic leukemia. B-cell chronic lymphocytic leukemia (B-CLL) is the most prevalent leukemia in the Western Hemisphere, accounting for \~25% of all leukemia's. It represents a monoclonal expansion of small, long-lived, apparently slowly dividing CD5+ B cells. Because of the low prolifera...
What is the current status of trial NCT01110850?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2001-06. Estimated completion is 2018-05-23.
Who is sponsoring clinical trial NCT01110850?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.